# A Study of the Effects of LY3372689 on the Brain in Healthy Participants

> **NCT03944031** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 17 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3372689
- **DIAGNOSTIC_TEST:** [18F]LSN3316612

## Key facts

- **NCT ID:** NCT03944031
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-08
- **Primary completion:** 2020-02-19
- **Final completion:** 2020-02-19
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03944031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03944031, "A Study of the Effects of LY3372689 on the Brain in Healthy Participants". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03944031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*